Skip to main content
SpringerLink
Log in

Recent Progress with Vaccines Against Epstein-Barr Virus Infection

  • Chapter
Immunological Adjuvants and Vaccines

Part of the book series: NATO ASI Series ((NSSA,volume 179))

  • 107 Accesses

Abstract

For well over a decade there has been strong evidence indicating that Epstein-Barr (EB) virus, one of the six human herpesviruses, forms an essential link in the complicated chain of events leading to the development of two human cancers (reviewed in Epstein and Achong, 1979), endemic Burkitt’s lymphoma (BL) (Burkitt, 1963) and undifferentiated nasopharyngeal carcinoma (NPC) (Shanmugaratnam, 1971). More recently, it has emerged that the virus also seems to be causally linked to the malignant lymphomas which arise with undue frequency in immunodepressed individuals (Purtillo, 1984).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allison, A.C. and Byars, N.E., 1986, An adjuvant formulation that selectively elicits the formation of antibodies of protective isotype and cell mediated immunity, J. Immunol.Methods, 95: 157.

    Article  PubMed  CAS  Google Scholar 

  • Beisel, C., Tanner, J., Matsuo, T., Thorley-Lawson, D., Kezdy, F. and Kieff, E., 1985, Two major outer envelope glycoproteins of Epstein-Barr virus encoded by the same gene, J.Virol., 54: 665.

    PubMed  CAS  Google Scholar 

  • Biggin, M., Farrell, P.J. and Barrell, B.G., 1984, Transcription and DNA sequence of the Bam HIL fragment of B95-8 Epstein-Barr Virus, EMBO.J., 3: 1083.

    PubMed  CAS  Google Scholar 

  • Burkitt, D., 1963, A lymphoma syndrome in tropical Africa, in: “International Review of Experimental Pathology”, G.W. Richter and M.A. Epstein, eds., Academic Press, New York.

    Google Scholar 

  • Cammoun, M., Hoerner, G.V. and Mourali, N., 1974, Tumors of the nasopharynx in Tunisia: an anatomic and clinical study based on 143 cases, Cancer, 3: 184.

    Article  Google Scholar 

  • Churchill, A.E., Payne, L.N. and Chubb, R.C., 1969, Immunization against Marek’s disease using a live attenuated virus, Nature, 221: 744.

    Article  PubMed  CAS  Google Scholar 

  • Cleary, M.L., Epstein, M.A., Finerty, S., Dorfman, R.F., Bornkamm, G.W., Kirkwood, J.K., Morgan, A.J. and Sklar, J., 1985, Individual tumors of multifocal EB virus-induced malignant lymphomas in tamarins arise from different B cell clones, Science, 228: 722.

    Article  PubMed  CAS  Google Scholar 

  • Clifford, P., 1970, A review: On the epidemiology of nasopharyngeal carcinoma, Int.J.Cancer, 5: 287.

    Article  PubMed  CAS  Google Scholar 

  • Conway, M., Morgan, A. and Mackett, M., 1988, Expression of Epstein-Barrvirus antigen gp340/220 in mouse fibroblasts using a bovine papilloma virus vector, submitted to press

    Google Scholar 

  • David, E.M. and Morgan, A.J., 1988, Efficient purification of Epstein-Barr virus membrane antigen gp340 by fast protein liquid chromatography, J. Immunol. Methods, 108: 231.

    Article  PubMed  CAS  Google Scholar 

  • Deinhardt, F. and Jilg, W., 1986, Vaccines against hepatitis, Ann. Inst. Pasteur, Virol., 137E:79.

    Google Scholar 

  • Doll, R. and Peto, R., 1976, Mortality in relation to smoking: 20 years’ observation on male British doctors, Brit. Med. J., 2: 1525.

    Article  PubMed  CAS  Google Scholar 

  • Epstein, M.A., 1976, Epstein-Barr virus — is it time to develop a vaccine program? J. Nat. Cancer Inst., 56: 697.

    PubMed  CAS  Google Scholar 

  • Epstein, M.A., 1984, A prototype vaccine to prevent Epstein-Barr (EB) virus-associated tumours, Proc.Roy.Soc.B.Lond., 221: 1.

    Article  CAS  Google Scholar 

  • Epstein, M.A. and Achong, B.G., 1979, “The Epstein-Barr Virus”, M.A. Epstein and B.G. Achong, eds., Springer, Berlin.

    Google Scholar 

  • Epstein, M.A., Morgan, A.J., Finerty, S., Rändle, B.J. and Kirkwood, J.K., 1985, Protection of cotton-top tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine, Nature, 318: 287.

    Article  PubMed  CAS  Google Scholar 

  • Henle, W. and Henle, G., 1969, The relation between the Epstein-Barr virus and infectious mononucleosis, Burkitt’s lymphoma and cancer of the postnasal space, E.African Med.J., 46: 402.

    CAS  Google Scholar 

  • Hummel, M., Thorley-Lawson, D.A. and Kieff, E., 1984, An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200), J.Virol., 49: 413.

    PubMed  CAS  Google Scholar 

  • International Agency for Research on Cancer, 1985, An intervention study to evaluate the effectiveness of Hepatitis B vaccine for the prevention of hepatocellular carcinoma in a high risk population, IARC Working Paper 3/6:1.

    Google Scholar 

  • Kaaden, O.R. and Dietzschold, B., 1974, Alterations of the immunological specificity of plasma membranes of cells infected with Marek’s disease and turkey herpes viruses, J.Gen.Virol., 25: 1.

    Article  PubMed  CAS  Google Scholar 

  • Kirkwood, J.K., Epstein, M.A. and Terlecki, A.J., 1983, Factors influencing population growth of a colony of cotton-top tamarins, Lab.Animals, 17: 35.

    Article  CAS  Google Scholar 

  • Kirkwood, J.K., Epstein, M.A, Terlecki, A.J. and Underwood, S.J., 1985, Rearing a second generation of cotton-top tamarins (Saguinus oedipus oedipus) in captivity, Lab.Animals, 19: 269.

    Article  CAS  Google Scholar 

  • Lowe, R.S., Keller, P.M., Keech, B.J., Davison, A.J., Whang, Y., Morgan, A.J., Kieff, E. and Ellis, R.W., 1987, Varicella-zoster virus as a live vector for the expression of foreign genes, Proc. Nat. Acad. Sci. USA, 84: 3896.

    Article  PubMed  CAS  Google Scholar 

  • Mackett, M. and Arrand, J.R., 1985, Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein-Barr virus membrane antigen gp340, EMBO, J., 4: 3229.

    CAS  Google Scholar 

  • Marek, J., 1907, Multiple Nervenentzündung (polyneuritis) bei Hühnern, Deutsch.Tierärztl Wschr., 15: 417.

    Google Scholar 

  • Miller, G., Shope, T., Coope, D., Waters, C., Pagano, J., Bornkamm, G.W. and Henle, W., 1977, Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum, antibody responses, demonstration of viral DNA, and characterization of viruses, J.Exp.Med., 145: 948.

    Article  PubMed  CAS  Google Scholar 

  • Morein, B., Lovgren, K., Hogland, S. and Sundquist, B., 1987, The iscom: an immunostimulating complex, Immunol. Today, 8: 333.

    Article  CAS  Google Scholar 

  • Morgan, A.J., Finerty, S., Lovgren, K., Scullion, F.T. and Morein, B., 1988, Prevention of Epstein-Barr (EB) virus-induced lyhmphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into Iscoms, J.Gen.Virol., in press.

    Google Scholar 

  • Morgan, A.J., Mackett, M., Finerty, S., Arrand, J., Scullion, F. and Epstein, M.A., 1988, Recombinant vaccinia viruses expressing Epstein-Barr virus glycoprotein gp340 protect cottontop tamarins against EB virus-induced malignant lymphomas, J. Med. Virol., in press.

    Google Scholar 

  • Morgan, A.J., North, J.R. and Epstein, M.A., 1983, Purification and properties of the gp340 component of Epstein-Barr (EB) virus membrane antigen (MA) in an immunogenic form, J.Gen.Virol., 64: 455.

    Article  PubMed  CAS  Google Scholar 

  • Moss, D.J. and Pope, J.H., 1972, Assay of the infectivity of the Epstein-Barr virus by transformation of human leucocytes in vitro, J. Gen. Virol., 17: 233.

    CAS  Google Scholar 

  • Niederman, J.C., Evans, A.S., Subrahmanyan, L. and McCollum, R.W., 1970, Prevalence, incidence and persistence of EB virus antibody in young adults, New Eng.J.Med., 282: 361.

    Article  PubMed  CAS  Google Scholar 

  • North, J.R., Morgan, A.J., Thompson, J.L. and Epstein, M.A., 1982, Quantification of an EB virus-associated membrane antigen (MA) component, J.Virol. Methods, 5: 55.

    Article  PubMed  CAS  Google Scholar 

  • Okazaki, W., Purchase, H.G. and Burmester, B.R., 1970, Protection against Marek’s disease by vaccination with a herpesvirus of turkeys, Avian Dis., 14: 413.

    Article  PubMed  CAS  Google Scholar 

  • Payne, L.N., Fraxier, J.A. and Powell, P.C., 1976, Pathogenesis of Marek’s disease, in: “International Review of Experimental Pathology”, G.W. Richter and M.A. Epstein, eds., Academic Press, New York.

    Google Scholar 

  • Pereira, M.A., Blake, J.M. and Macrae, A.D., 1969, EB virus antibody at different ages, Brit.Med. J., 4: 526.

    Article  PubMed  CAS  Google Scholar 

  • Purtilo, D.T., 1984, Immune deficiency and cancer. Epstein-Barr virus and lymphoproliferative malignancies, Plenum Medical Book Co., New York.

    Google Scholar 

  • Randle, B.J. and Epstein, M.A., 1984, A highly sensitive enzyme-linked immunosorbent assay to quantitate antibodies to Epstein-Barr virus membrane antigen gp340, J.Virol. Methods, 9: 201.

    Article  PubMed  CAS  Google Scholar 

  • Rickinson, A.B., 1986, Cellular immunological responses to the virus infection in: “The Epstein-Barr virus: Recent Advances”, M.A. Epstein and B.G. Achong, eds., William Heinemann Medical Books, London.

    Google Scholar 

  • de Schryver, A., Klein, G., Hewetson, J., Rocchi, G., Henle, W., Henle, G., Moss, D.J. and Pope, J.H., 1974, Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti MA), Int. J. Cancer, 13: 353.

    Article  PubMed  Google Scholar 

  • Schultz, L.D., Tanner, J., Hofmann, K., Emini, E., Kieff, E. and Ellis, R.W., 1987, Expression and analysis of EBV gp350 in yeast Saccharomyces cerevisiae, in: “Epstein-Barr Virus and Human Disease”, P.H. Levine, D.V. Ablashi, M. Nonoyama, G.R. Pearson and R. Glaser, eds., Humana Press, Clifton.

    Google Scholar 

  • Shanmugaratnam, K., 1971, Studies on the etiology of nasopharyngeal carcinoma, in: “International Review of Experimental Pathology”, G.W. Richter and M.A. Epstein, eds., Academic Press, New York.

    Google Scholar 

  • Takahashi, M., Otsuka, T., Okuno, Y., Asano, Y., Yazaki, T. and Isomura, S., 1974, Live varicella vaccine used to prevent the spread of varicella in children in hospital, Lancet ii: 1288.

    Article  Google Scholar 

  • de Thé, G., 1979, Demographic studies implicating the virus in the causation of Burkitt’s lymphoma; prospects for nasopharyngeal carcinoma, in: “The Epstein-Barr Virus”, M.A. Epstein and B.G. Achong, eds., Springer, Berlin.

    Google Scholar 

  • University Health Physicians and PHLS Laboratories, 1971, Infectious mononucleosis and its relationship to EB virus antibody, Brit. Med. J., iv: 643.

    Google Scholar 

  • Weibel, R.E., Neff, B.J., Kuter, B.J., Guess, H.A., Rothenburger, C.A. Fitzgerald, A.J., Connor, K.A., McLean, A.A., Hilleman, M.R. and Buynak, E.B., 1984, Live attenuated varicella virus vaccine: efficiency trial in healthy children, New Eng.J.Med., 310: 1409.

    Article  PubMed  CAS  Google Scholar 

  • Whang, Y., Silberklang, M., Morgan, A., Munshi, S., Lenny, A.B., Ellis, R.W. and Kieff, E., 1987, Expression of Epstein-Barr virus gp350/220 gene in rodent and primate cells, J.Virol., 61: 1796.

    PubMed  CAS  Google Scholar 

  • Zuckerman, A.J., 1985, Prevention of hepatocellular carcinoma by immunization against hepatitis B, in: “International Review of Experimental Pathology”, G.W. Richter and M.A. Epstein, eds., Academic Press, Orlando.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital Headington, Oxford, 0X3 9DU, UK

    M. A. Epstein

Authors
  1. M. A. Epstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Royal Free Hospital School of Medicine, London, UK

    Gregory Gregoriadis

  2. Syntex Research, Palo Alto, California, USA

    Anthony C. Allison

  3. Smith Kline French Laboratories, Philadelphia, Pennsylvania, USA

    George Poste

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Press, New York

About this chapter

Cite this chapter

Epstein, M.A. (1989). Recent Progress with Vaccines Against Epstein-Barr Virus Infection. In: Gregoriadis, G., Allison, A.C., Poste, G. (eds) Immunological Adjuvants and Vaccines. NATO ASI Series, vol 179. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0283-5_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-0283-5_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-0285-9

  • Online ISBN: 978-1-4757-0283-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation